Estudio del papel de la GTPasa RAB11 en cáncer de próstata para su uso como biomarcador

Anticancer Activity Driven by Drug Linker Modification in a Polyglutamic Acid-Based Combination-Drug Conjugate

Arroyo-Crespo, JJ; (...); Vicent, MJ

Article. 10.1002/adfm.201800931. 2018

Design of personalised polymer based combination therapeutics for advanced stage breast cancer patients

Arminan, A; (...); Vicent, MJ

Meeting Abstract. 10.1158/1538-7445.AM2018-3726. 2018

High-throughput screening of new drugs targeting lung CSCs

Labrador, HAA; (...); Camps, C

Meeting Abstract. 2018

Metabolomics facilitates the discrimination of the specific and-cancer effects of free and polymer conjugated doxorubicin in breast cancer models

Arminan, A; (...); Pineda-Lucena, A

Article. 10.1016/j.biomaterials.2018.02.015. 2018

• 
• Documentos

Polyacetal-Based Combination Therapy for the Treatment of Prostate Cancer

Plyduang, T; (...); Vicent, MJ

Article. 10.1002/marc.201800265. 2018

Tumor microenvironment-targeted poly-L-glutamic acid-based combination conjugate for enhanced triple negative breast cancer treatment

Arroyo-Crespo JJ; (...); Vicent MJ

Article. 10.1016/j.biomaterials.2018.09.023. 2018

• 
• Documentos